Forgotten Memories of Traumatic Events Get Some Backing from Brain-Imaging Studies
A new wave of research seeks neurological signatures for a type of amnesia
A new wave of research seeks neurological signatures for a type of amnesia
Calling the condition a disorder falsely implies we know of a cause located in the brains of people diagnosed with it—and we don’t
Delirium is very common on COVID wards. Researchers are testing whether these temporary bouts of confusion could bring on permanent cognitive decline
Pulses of light and sound helped mice predisposed to the disease. Researchers hope to investigate the potential therapy for humans with neurons created in a petri dish
New assays could reduce the need for costlier, more invasive brain scans and spinal fluid measures
The virus induces neurological symptoms that persist long after the pandemic ends
Making predictions up to several days in advance may help with care
Brain-scan studies hint that the ancient practice may benefit areas associated with memory, emotion and thinking
A mysterious condition once dismissed as hysteria is challenging the divide between neurology and psychiatry
New models used writing samples to predict the onset of the disease with 70 percent accuracy
Neurological symptoms might arise from multiple causes. But does the virus even get into neurons?
Targeting recall processes could let people who are in the disease’s early stages access what they currently can’t remember
His start-up Neuralink is not the first to develop a wireless brain implant. But the considerable resources behind the effort could help commercialize the technology faster
Research suggests that cultural beliefs about the phenomenon may make it more terrifying to experience
Sleep hygiene is so bad at treating insomnia that it's used as the placebo in clinical sleep trials. Before you buy darker blackout curtains, try these expert tips
Toxic airborne particles can travel from lungs and nose to the brain, and exposure is linked to memory loss
Rigorous new studies should be able to settle the matter
Being female is a risk factor for Alzheimer’s. Why?
Amyloid, the leading target for dementia therapy, faces skepticism after drug failures
Here are some “highlights” from the past 13.5 years of this podcast.
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account